...
mlab-img

Mesa Laboratories Inc, Common Stock

MLAB

NSQ

$113.9

+$0.28

(0.25%)

1D
Industry: Life Sciences Tools & Services Sector: Health Care

Analyst Forecast

Price Chart

Key Metrics

Market Cap info-icon
This is a company’s total value as determined by the stock market. It is calculated by multiplying the total number of a company's outstanding shares by the current market price of one share.
$617.12M
P/E Ratio info-icon
This is the ratio of a security’s current share price to its earnings per share. This ratio determines the relative value of a company’s share.
0
Volume info-icon
This is the total number of shares traded during the most recent trading day.
12.13K
Avg Volume info-icon
This is the average number of shares traded during the most recent 30 days.
0
Dividend Yield info-icon
This ratio shows how much income you earn in dividend payouts per year for every dollar invested in the stock (or the stock’s annual dividend payment expressed as a percentage of its current price).
0.56%
Beta info-icon
This measures the expected move in a stock’s price relative to movements in the overall market. The market, such as the S&P 500 Index, has a beta of 1.0. If a stock has a Beta greater (or lower) than 1.0, it suggests that the stock is more (or less) volatile than the broader market.
0.86
52-week Range info-icon
This shows the range of the stock’s price between the 52-week high (the highest price of the stock for the past 52 weeks) and the 52-week low (the lowest price of the stock for the past 52 weeks).
$83.58 L
$141 H
$113.9

About Mesa Laboratories Inc, Common Stock

Mesa Laboratories, Inc. develops, designs, manufactures, sells, and services life sciences tools and quality control products and services in North America, Europe, the Asia Pacific, and internationally. The Sterilization and Disinfection Control segment offers biological, chemical, and cleaning indicators, used to assess the effectiveness of sterilization decontamination, disinfection, and cleaning processes in the pharmaceutical, medical device, and healthcare industries. This segment also provides testing and laboratory services to the dental and pharmaceutical industries. The Clinical Genomics segment offers MassARRAY, a genetic analysis tool system, and related consumables, including chips, panels, and chemical reagent solutions used by clinical labs to analyze DNA samples for inherited genetic disease testing, pharmacogenetics, oncology testing, infectious disease testing, doping and toxicology testing, and other differentiated applications for use in research. The Biopharmaceutical Development segment provides automated systems, such as Gyrolab xPand and Gyrolab xPlore hardware and software, Gyrolab Bioaffy consumable microfluidic disks, Gyrolab kits and Rexxip buffers for protein analysis; PurePep Chorus and Symphony instruments for peptide synthesis; and PurePep EasyClean products for purifying peptides. The Calibration Solutions segment offers quality control products to measure and calibrate critical parameters in applications, such as environmental and process monitoring, dialysis, gas flow, air quality, and torque testing in medical device and pharmaceutical manufacturing, laboratory, and hospital environments. This segment's products include continuous monitoring systems, dialysate meters and consumables, data loggers, gas flow calibration and air sampling equipment, and torque testing systems, offered under DialyGuard, ViewPoint, DataTrace, DryCal, and BGI brands. The company was incorporated in 1982 and is headquartered in Lakewood, Colorado. more

Industry: Life Sciences Tools & ServicesSector: Health Care

Returns

Time FrameMLABSectorS&P500
1-Week Return10.26%2.43%1.57%
1-Month Return0.51%-2.15%3.19%
3-Month Return-17.52%-6.42%6.57%
6-Month Return-0.55%1.91%12.75%
1-Year Return31.44%11.57%31.51%
3-Year Return-63.68%10.17%30.11%
5-Year Return-52.45%46.25%90.82%
10-Year Return56.46%111.45%189.07%

Financials

Mar '20Mar '21Mar '22Mar '23Mar '245YR TREND
Total Revenue117.69M133.94M184.34M219.08M216.19M[{"date":"2020-03-31","value":53.72,"profit":true},{"date":"2021-03-31","value":61.14,"profit":true},{"date":"2022-03-31","value":84.14,"profit":true},{"date":"2023-03-31","value":100,"profit":true},{"date":"2024-03-31","value":98.68,"profit":true}]
Cost of Revenue52.75M46.92M75.25M85.39M82.94M[{"date":"2020-03-31","value":61.78,"profit":true},{"date":"2021-03-31","value":54.95,"profit":true},{"date":"2022-03-31","value":88.12,"profit":true},{"date":"2023-03-31","value":100,"profit":true},{"date":"2024-03-31","value":97.13,"profit":true}]
Gross Profit64.93M87.01M109.09M133.69M133.25M[{"date":"2020-03-31","value":48.57,"profit":true},{"date":"2021-03-31","value":65.08,"profit":true},{"date":"2022-03-31","value":81.6,"profit":true},{"date":"2023-03-31","value":100,"profit":true},{"date":"2024-03-31","value":99.67,"profit":true}]
Gross Margin55.17%64.97%59.18%61.02%61.64%[{"date":"2020-03-31","value":84.93,"profit":true},{"date":"2021-03-31","value":100,"profit":true},{"date":"2022-03-31","value":91.09,"profit":true},{"date":"2023-03-31","value":93.93,"profit":true},{"date":"2024-03-31","value":94.87,"profit":true}]
Operating Expenses57.14M74.66M104.39M130.37M406.55M[{"date":"2020-03-31","value":14.05,"profit":true},{"date":"2021-03-31","value":18.36,"profit":true},{"date":"2022-03-31","value":25.68,"profit":true},{"date":"2023-03-31","value":32.07,"profit":true},{"date":"2024-03-31","value":100,"profit":true}]
Operating Income(4.90M)(5.30M)(20.37M)(30.50M)(272.07M)[{"date":"2020-03-31","value":-490000000,"profit":false},{"date":"2021-03-31","value":-530200000,"profit":false},{"date":"2022-03-31","value":-2036600000,"profit":false},{"date":"2023-03-31","value":-3050400000,"profit":false},{"date":"2024-03-31","value":-27207500000,"profit":false}]
Total Non-Operating Income/Expense3.79M(17.97M)(5.01M)(8.48M)(9.27M)[{"date":"2020-03-31","value":100,"profit":true},{"date":"2021-03-31","value":-474.32,"profit":false},{"date":"2022-03-31","value":-132.3,"profit":false},{"date":"2023-03-31","value":-223.78,"profit":false},{"date":"2024-03-31","value":-244.66,"profit":false}]
Pre-Tax Income3.43M2.30M3.57M(389.00K)(275.65M)[{"date":"2020-03-31","value":96.05,"profit":true},{"date":"2021-03-31","value":64.44,"profit":true},{"date":"2022-03-31","value":100,"profit":true},{"date":"2023-03-31","value":-10.88,"profit":false},{"date":"2024-03-31","value":-7712.59,"profit":false}]
Income Taxes2.08M(971.00K)1.70M(1.32M)(21.40M)[{"date":"2020-03-31","value":100,"profit":true},{"date":"2021-03-31","value":-46.59,"profit":false},{"date":"2022-03-31","value":81.72,"profit":true},{"date":"2023-03-31","value":-63.29,"profit":false},{"date":"2024-03-31","value":-1026.97,"profit":false}]
Income After Taxes1.35M3.27M1.87M930.00K(254.25M)[{"date":"2020-03-31","value":41.2,"profit":true},{"date":"2021-03-31","value":100,"profit":true},{"date":"2022-03-31","value":57.15,"profit":true},{"date":"2023-03-31","value":28.41,"profit":true},{"date":"2024-03-31","value":-7765.61,"profit":false}]
Income From Continuous Operations1.35M3.27M1.87M930.00K(254.25M)[{"date":"2020-03-31","value":41.2,"profit":true},{"date":"2021-03-31","value":100,"profit":true},{"date":"2022-03-31","value":57.15,"profit":true},{"date":"2023-03-31","value":28.41,"profit":true},{"date":"2024-03-31","value":-7765.61,"profit":false}]
Income From Discontinued Operations-----[{"date":"2020-03-31","value":"-","profit":true},{"date":"2021-03-31","value":"-","profit":true},{"date":"2022-03-31","value":"-","profit":true},{"date":"2023-03-31","value":"-","profit":true},{"date":"2024-03-31","value":"-","profit":true}]
Net Income1.35M3.27M1.87M930.00K(254.25M)[{"date":"2020-03-31","value":41.2,"profit":true},{"date":"2021-03-31","value":100,"profit":true},{"date":"2022-03-31","value":57.15,"profit":true},{"date":"2023-03-31","value":28.41,"profit":true},{"date":"2024-03-31","value":-7765.61,"profit":false}]
EPS (Diluted)0.840.581.350.163.76[{"date":"2020-03-31","value":22.34,"profit":true},{"date":"2021-03-31","value":15.43,"profit":true},{"date":"2022-03-31","value":35.9,"profit":true},{"date":"2023-03-31","value":4.26,"profit":true},{"date":"2024-03-31","value":100,"profit":true}]

Ratios

Liquidity

These ratios help you determine the liquidity of the company. Higher is better.

MLAB
Cash Ratio 0.16
Current Ratio 0.70
Quick Ratio 0.51

Asset Efficiency

These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.

MLAB
ROA (LTM) 1.69%
ROE (LTM) -89.46%

Liabilities

These ratios help you understand the company's liabilities, gauging the riskiness of the investment.

MLAB
Debt Ratio Lower is generally better. Negative is bad. 0.64
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier. 0.36

Valuation

These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.

MLAB
Trailing PE NM
Forward PE 35.21
P/S (TTM) 2.70
P/B 3.82
Price/FCF 177
EV/R 3.57
EV/Ebitda 305.65
PEG NM

FAQs

What is Mesa Laboratories Inc share price today?

Mesa Laboratories Inc (MLAB) share price today is $113.9

Can Indians buy Mesa Laboratories Inc shares?

Yes, Indians can buy shares of Mesa Laboratories Inc (MLAB) on Vested. To buy Mesa Laboratories Inc from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in MLAB stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.

Can Fractional shares of Mesa Laboratories Inc be purchased?

Yes, you can purchase fractional shares of Mesa Laboratories Inc (MLAB) via the Vested app. You can start investing in Mesa Laboratories Inc (MLAB) with a minimum investment of $1.

How to invest in Mesa Laboratories Inc shares from India?

You can invest in shares of Mesa Laboratories Inc (MLAB) via Vested in three simple steps:

  • Click on Sign Up or Invest in MLAB stock at the top of this page
  • Breeze through our fully digital and secure KYC process and open your US Brokerage account in a few minutes
  • Transfer USD funds to your US Brokerage account and start investing in Mesa Laboratories Inc shares
What is Mesa Laboratories Inc 52-week high and low stock price?

The 52-week high price of Mesa Laboratories Inc (MLAB) is $141. The 52-week low price of Mesa Laboratories Inc (MLAB) is $83.58.

What is Mesa Laboratories Inc price-to-earnings (P/E) ratio?

The price-to-earnings (P/E) ratio of Mesa Laboratories Inc (MLAB) is

What is Mesa Laboratories Inc price-to-book (P/B) ratio?

The price-to-book (P/B) ratio of Mesa Laboratories Inc (MLAB) is 3.82

What is Mesa Laboratories Inc dividend yield?

The dividend yield of Mesa Laboratories Inc (MLAB) is 0.56%

What is the Market Cap of Mesa Laboratories Inc?

The market capitalization of Mesa Laboratories Inc (MLAB) is $617.12M

What is Mesa Laboratories Inc’s stock symbol?

The stock symbol (or ticker) of Mesa Laboratories Inc is MLAB

Signup to access all features and start your US investing journey!

  • Open your account in minutes
  • Take your portfolio global, starting at just $1
Get started

Add ticker to compare

Scroll to Top